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The founding member of the inhibitor of apoptosis protein (IAP) family was originally identified as a cell
death inhibitor. However, recent evidence suggests that IAPs are multifunctional signaling devices that
influence diverse biological processes. To investigate the in vivo function of Drosophila melanogaster IAP2, we
have generated diap2 null alleles. diap2 mutant animals develop normally and are fully viable, suggesting that
diap2 is dispensable for proper development. However, these animals were acutely sensitive to infection by
gram-negative bacteria. In Drosophila, infection by gram-negative bacteria triggers the innate immune re-
sponse by activating the immune deficiency (imd) signaling cascade, a NF-B-dependent pathway that shares
striking similarities with the pathway of mammalian tumor necrosis factor receptor 1 (TNFR1). diap2 mutant
flies failed to activate NF-B-mediated expression of antibacterial peptide genes and, consequently, rapidly
succumbed to bacterial infection. Our genetic epistasis analysis places diap2 downstream of or in parallel to
imd, Dredd, Tak1, and Relish. Therefore, DIAP2 functions in the host immune response to gram-negative
bacteria. In contrast, we find that the Drosophila TNFR-associated factor (Traf) family member Traf2 is
dispensable in resistance to gram-negative bacterial infection. Taken together, our genetic data identify DIAP2
as an essential component of the Imd signaling cascade, protecting the organism from infiltrating microbes.
Drosophila melanogaster lacks an adaptive immune system
and relies exclusively on innate immune reactions for its de-
fense against microbial infection. Activation of the innate im-
mune response leads to the expression of hundreds of genes,
some of which encode potent antimicrobial peptides that are
synthesized in immunocompetent tissues, such as the tracheal
epithelium, circulating “blood” cells, and fat body, the ana-
logue of the mammalian liver (19).
Depending on the infecting microbe, Drosophila activates
the Toll or immune deficiency (Imd) signaling pathway. Expo-
sure to fungi or gram-positive bacteria activates a serine-pro-
tease cascade, through pattern recognition molecules (10), that
triggers cleavage and activation of Spatzle. Spatzle, in turn,
binds and activates the transmembrane Toll receptor, which
engages an intracellular signaling cascade that results in nu-
clear translocation of the NF-B-like transcription factors Dif
and Dorsal. Dif and Dorsal then induce expression of droso-
mycin, a potent antifungal peptide. In contrast, the Imd path-
way is activated in response to gram-negative bacteria. Di-
aminopimelic acid-type peptidoglycan (DAP-PG), a major
component of the gram-negative bacterial cell wall, is recog-
nized by the pattern recognition protein peptidoglycan recogni-
tion protein LE (PGRP-LE) and the transmembrane receptor
PGRP-LC. Upon binding to DAP-PG, PGRP-LC triggers nu-
clear translocation of the NF-B-like transcription factor Relish,
which, among others, induces expression of the antibacterial pep-
tide gene Diptericin via the Imd pathway (20, 38).
The Imd pathway shares striking similarities with the tumor
necrosis factor receptor 1 (TNFR1) signaling cascade (48).
Following exposure to pathogens, PGRP-LC activates Imd,
which carries a C-terminal death domain that is similar to the
domain of the mammalian adaptor protein receptor-interact-
ing protein 1 (RIP1) (11). Through this death domain, Imd
recruits dFADD and the Drosophila caspase 8 orthologue
Dredd to the PGRP-LC receptor (4, 28, 29, 33). Microbe-
driven complex formation triggers activation of the Drosophila
mitogen-activated protein kinase kinase kinase Tak1 and the
Relish kinase complex Ird5/Kenny (IB kinase  [IKK]/IKK
complex) (31, 39, 44, 51). The similarities between Imd and
TNFR1 signaling also extend to ubiquitin-mediated activation
of IKK (3). As in mammals, Drosophila Ubc13(Bendless)/
UEV1A, an E2 ubiquitin-protein conjugase complex that pro-
motes K63-linked polyubiquitylation, is required for the acti-
vation of Tak1 and the IKK complex (57). Relish activation
requires at least two posttranslational modifications, phosphor-
ylation and Dredd-dependent proteolytic cleavage (44–46).
These changes enable translocation of Relish to the nucleus
and expression of antibacterial peptide genes. However, recent
in vivo evidence suggests that Tak1-mediated Jun N-terminal
protein kinase (JNK) activation, in addition to Relish activa-
tion, is required for antimicrobial peptide gene expression (9).
These data are consistent with a model whereby Imd signaling
bifurcates at the level of Tak1, which activates both JNK and
IKK signaling. Thus, a cooperative input from JNK and NF-B
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signaling seems to be required for full induction of antibacte-
rial peptide gene expression in response to bacterial infection
(see Fig. 8). Loss-of-function mutations in any of the compo-
nents of the Imd signaling cascade result in the same immune
deficiency phenotype, in which animals become acutely suscep-
tible to infection by gram-negative bacteria. Common to all
these mutants is their failure to induce expression of antibac-
terial peptide genes and, therefore, to fend off bacterial infec-
tion (38).
Signaling through the mammalian TNFR1 also results in the
recruitment of cellular inhibitor of apoptosis protein 1 (c-
IAP1) and c-IAP2, two members of the evolutionarily con-
served IAP family (37, 41). Although IAPs were originally
identified as inhibitor of apoptosis proteins (7), recent evi-
dence suggests that IAPs also fulfill functions that operate
independently of their ability to control caspases and cell death
(50). Thus, c-IAP1 and c-IAP2, through their ability to bind to
TNFR1, TNFR-associated factor 2 (TRAF2), and RIP1, are
implicated in modulating TNFR1 signaling. However, due to
redundancy or compensatory mechanisms among these IAPs,
mutant animals did not display aberrant TNFR1 signaling
(5, 6, 42). Recent genome-wide RNA interference (RNAi)
screens in cultured cells as well as in vivo RNAi analysis iden-
tified the Drosophila inhibitor of apoptosis 2 (DiAP2) as a
potential component of the Drosophila Imd pathway (12, 23).
However, due to lack of diap2 mutant animals, the physiolog-
ical role of DIAP2 for Drosophila immune responses is not
fully established.
To investigate the in vivo function of DIAP2, we have gen-
erated diap2 null alleles. diap2 mutant animals develop nor-
mally and are fully viable, suggesting that diap2 is dispensable
for proper development. However, these animals were acutely
sensitive to infection by gram-negative bacteria. Consistently,
diap2 mutant flies failed to induce expression of the antibac-
terial peptide genes and, hence, to mount a proper innate
immune response. Thus, our data unambiguously demonstrate
that DIAP2 is an essential component of the Imd signaling
cascade in vivo, protecting flies from microbial infection.
MATERIALS AND METHODS
Fly stocks. OregonR and CantonS flies were used as wild-type controls.
spatzlerm7, Tak11, RelishE20, and Traf2Ex1 alleles, Hsp-GAL4, Act5c-GAL4, Da-
GAL4 drivers, upstream activation sequence (UAS)-imd, hsp-GAL4, UAS-Tak1,
UAS-Relish (full-length) and UAS-Dredd transgenic flies were described previ-
ously (2, 18, 29, 51). The EP(G2326) line was purchased from Genexel Inc.
(Daejeon, South Korea). Df(2R)exel7138 spans the diap2 locus (35). diap27c and
diap27a alleles were generated by transposase-mediated imprecise excision of
EP(G2326) and mapped as indicated below. The UAS-diap2 construct was gen-
erated by cloning the diap2 open reading frame in EcoRI/XhoI-digested pUAST
vector. w1118 flies were used to generate UAS-diap2 transgenic flies. An insertion
of this construct on the third chromosome was used in this study. Drosophila
stocks and crosses were maintained at 25°C. Following septic injury, flies were
incubated at either 25°C for quantitative reverse transcription-PCR (RT-PCR)
analysis or 29°C for survival assays. Heat shock-mediated induction of imd, Tak1,
Relish, and Dredd overexpression was performed at 37°C for 1 h, followed by a
recovery phase at 25°C.
Analysis of genomic lesions. Genomic DNA from homozygous diap27c and
diap27a flies was extracted from an adult individual as described previously (13).
Five microliters of genomic DNA was used for PCR amplification using Easy-A
High-Fidelity PCR cloning enzyme (Stratagene, United Kingdom). The follow-
ing oligonucleotide primers were used to amplify the diap2 locus: 5-CGGGGC
ACATCACTTGAAGACCG-3 and 5-GGCATTGCCCATGGGCTTAAGC-
3). The resulting PCR product was purified, cloned into pGEMt vector
(Promega), and analyzed by DNA sequencing.
Immunoblot analysis. Protein extracts were prepared from five adults or
third-instar larvae by snap-freezing, homogenizing, and boiling in Laemmli
buffer. Protein samples were analyzed by immunoblotting with anti-DIAP1 (55),
anti-DIAP2, and antitubulin antibodies (Sigma, United Kingdom). Anti-DIAP2
was generated in rabbit using a purified, recombinant DIAP2 fragment spanning
the baculovirus IAP repeat 3 (BIR3) region (amino acids 215 to 281). For
immunoblot detection and quantification of signals, Odyssey technology was
used according to the manufacturer’s instructions (Licor Biosciences, United
Kingdom).
Bacterial strains, infection experiments, and survival analysis. Microbial sep-
tic injuries were performed by pricking third-instar larvae in the posterior region
or adults in the lateral part of the thorax with a thin needle previously dipped into
a concentrated (optical density of 200) culture of Erwinia carotovora subsp.
carotovora 15, Micrococcus luteus, Enterococcus faecalis, or Candida albicans. For
natural infection by Erwinia carotovora subsp. carotovora 15, Drosophila third-
instar larvae were exposed to a mixture of crushed banana and bacteria as
described previously (1). For the survival experiments, flies were examined at
different time points to monitor survival after septic injury. The infected flies
were transferred to fresh vials daily. The experiments were performed using at
least 40 flies for each genotype.
Quantitative real-time PCR. For quantitative analysis of Attacin-A, Cecropin-
A1, Defensin, Diptericin, Drosocin, Drosomycin, Metchnikowin, and rp49 mRNA
expression, RNA was extracted from whole animals using RNA TRIzol (Invitro-
gen). cDNAs were synthesized using SuperScript II (Invitrogen) and quantitative
PCR was performed using double-stranded DNA dye SYBR green I (Roche
Diagnostics). Primer pairs were as follows: for Attacin-A, sense, 5-CCCGGAG
TGAAGGATG-3, antisense, 5-GTTGCTGTGCGTCAAG-3; for Cecropin-
A1, sense, 5-GAACTTCTACAACATCTTCGT-3, antisense, 5TCCCAGTCC
CTGGATT-3; for Defensin, sense, 5-GTTCTTCGTTCTCGTGG-3, antisense,
5-CTTTGAACCCCTTGGC-3; for Diptericin, sense, 5-GCTGCGCAATCGC
TTCTACT-3, antisense, 5-TGGTGGAGTGGGCTTCATG-3; for Drosocin,
sense, 5-CCATCGTTTTCCTGCT-3, antisense, 5-CTTGAGTCAGGTGATC
C-3; for Drosomycin, sense, 5-CGTGAGAACCTTTTCCAATATGATG-3,
antisense, 5-TCCCAGGACCACCAGCAT-3; for Metchnikowin, sense, 5-AA
CTTAATCTTGGAGCGA-3, antisense, 5-CGGTCTTGGTTGGTTAG-3; and
for rp49, sense, 5-GACGCTTCAAGGGACAGTATCTG-3, antisense, 5-AAAC
GCGGTTCTGCATGAG-3. SYBR green analysis was performed on a Lightcycler
(Roche Diagnostics). The amount of mRNA detected was normalized to control
rp49 mRNA values. We used normalized data to quantify the relative levels of a
given mRNA according to cycling threshold analysis.
RESULTS
Generation of diap2 null mutant flies. To elucidate the in
vivo function of DIAP2, we created a null allele of diap2 by
screening for imprecise excisions of an existing P element,
EP(G2326) (Genexel Inc.) (Fig. 1A). EP(G2326) is inserted at
position 11449676 (Drosophila genome release 4.2.1), which is
located 12 nucleotides (nt) 3 of the transcriptional start site of
the diap2-RB transcript, and 69 nt 5 of the transcriptional
start site of the diap2-RA transcript. We obtained two mutants,
diap27a and diap27c, which carried deletions that removed the
start codon and extended 371 nt (diap27a) and 735 nt (diap27c)
into the coding region of DIAP2. Thus, diap27a lacks the
entire first exon (778-bp genomic deletion, from 11449676 to
11448898), while diap27c lacks exon one and most of exon two
(1,357-bp genomic deletion, from 11449676 to 11448319) (Fig.
1A). Immunoblot analysis with an anti-DIAP2 antibody, raised
against the BIR3 domain of DIAP2, indicated that DIAP2
protein was not detectable in diap27a and diap27c homozygous,
diap27a/diap27c transheterozygous, or diap27c/Def(2R)exel7138
(diap27c/def) hemizygous mutant animals. In contrast, DIAP2
protein was readily detectable in animals of the parental
EP(G2326) line as well as in diap27c/ or def/ individuals
(Fig. 1B and data not shown). Importantly, the deletions in
diap27a and diap27c did not affect the transcriptional start site
and open reading frame of the nearby gene CG8297 (Fig. 1A
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and data not shown). Taken together, these results suggest that
diap27c and diap27a are null alleles of diap2.
Knockout studies and biochemical characterization of mamma-
lian IAPs have revealed homeostatic cross-regulation among cer-
tain IAPs, whereby loss of one IAP can cause compensatory
upregulation of family members (6, 15, 42). To address whether
loss of DIAP2 resulted in increased levels of DIAP1, we ana-
lyzed DIAP1 protein levels in diap2 mutant flies by quantita-
tive Western blot analysis. As shown in Fig. 1C, DIAP1 levels
remained unchanged in diap2 mutant flies compared to wild-
type flies.
Loss of diap2 renders flies susceptible to septic injury with
gram-negative bacteria. Most diap27c/def hemizygous mutant
individuals survived embryogenesis and developed normally
(86% survival, n  506 for diap27c/def). Thus, in contrast to
diap1 mutant animals that die early during embryogenesis with
deregulated caspase activity (14, 30, 54), loss of zygotic expres-
sion of diap2 did not confer such a phenotype. Although diap2
mutants showed no obvious developmental defects, we noticed
that diap2 mutant flies were acutely sensitive to infections. To
investigate the potential implication of diap2 in the regulation
of Drosophila immune response in vivo, we analyzed the sur-
vival profile of diap2 mutant flies in different models of micro-
bial infection by septic injury, an established system to analyze
Drosophila immune phenotypes (49). To this end, we infected
wild-type and mutant flies with the gram-negative bacterium
Erwinia carotovora subsp. carotovora 15 (Fig. 2A), the gram-
positive bacterium Enterococcus faecalis (Fig. 2B), or the fun-
gus Candida albicans (Fig. 2C). Infection by gram-negative
bacteria activates the Imd signal transduction pathway, which
results in the expression of antibacterial peptide genes. Flies
with mutations in Tak1 (Tak11) and Relish (RelishE20), two
components of the Imd pathway, failed to mount such an Imd
response and consequently succumbed to infection by E. caro-
tovora subsp. carotovora 15 (Fig. 2A) (51). By contrast, a mu-
tation in the spatzle gene (spatzlerm7), which blocks Toll acti-
vation, sensitized animals only to infection by gram-positive
bacteria and fungi (Fig. 2B and C) (25, 40). Interestingly, we
found that, similar to Tak11 and RelishE20 mutant flies, diap2
mutant individuals (diap27c/def) were highly susceptible to in-
jection of the gram-negative bacterium E. carotovora subsp.
carotovora 15 (Fig. 2A) (51), but not gram-positive bacteria
(Fig. 2B) and fungi (Fig. 2C) (36). The survival rate of diap27c/
def hemizygous mutant animals was almost identical to those of
diap27c and diap27a homozygous or diap27a/diap27c transhet-
erozygous mutant animals (Fig. 2A), establishing that diap27c
and diap27a are genetically null alleles. Moreover, flies from
the parental EP(G2326) line, which was used to generate the
diap27c and diap27a alleles, showed no susceptibility to E.
carotovora subsp. carotovora 15 injection (Fig. 2A). This con-
firms that the observed immune deficiency phenotype relies on
the deletion generated by imprecise excision of EP(G2326).
Next, we addressed whether the observed susceptibility to E.
carotovora subsp. carotovora 15 infection in diap2 mutant flies
was indeed due to mutation in diap2. We took advantage of the
yeast UAS/GAL4 binary system to constitutively express a
wild-type diap2 transgene in otherwise diap2 mutant flies. Ex-
pression of the UAS-diap2 transgene was driven by either the
GAL4 driver Daughterless-GAL4 (Da-GAL4) or Actin5c-
GAL4 (Act5c-GAL4), which express GAL4 constitutively in all
cells. Quantitative Western blot analysis was used to determine
diap2 transgene expression levels in otherwise diap27c homozy-
gous mutant flies. While diap27c mutant animals were devoid
of DIAP2 protein, “leaky” expression (in the absence of a
GAL4 driver) of the UAS-diap2 transgene resulted in small,
but significant, amounts of DIAP2 protein levels (31% of the
DIAP2 protein levels observed in wild-type flies [Fig. 3A, lane
4]). In contrast, Act5c- or Da-GAL4-driven expression of UAS-
diap2 resulted in DIAP2 protein levels that were 64% and 61%
FIG. 1. Generation of DIAP2-deficient flies. (A) Imprecise exci-
sion of EP(G2326) created diap27c and diap27a alleles that carry dele-
tions, which removed large portions of the diap2 locus. Schematic
representation depicting the diap2 locus, the insertion site and orien-
tation of EP(G2326), and the genomic DNA. The positions of the
primers used to clone the respective genomic DNA fragments are
indicated. (B) DIAP2 protein levels were undetectable in diap2 mutant
flies. The presence of DIAP2 protein was examined by immunoblot
analysis using anti-DIAP2 antibodies. Protein extracts from the fol-
lowing genotypes were used to monitor DIAP2 expression: diap27c/
Cyo-actGFP (diap27c/, third-instar larvae [L3]) (lane 1), diap27c
(third-instar larvae) (lane 2), CantonS (wild type [WT], adult) (lane 3),
EP(G2326) (adult) (lane 4), diap27c/Df(2R)exel7138 (diap27c/def, adult)
(lane 5), diap27c (adult) (lane 6), diap27a (adult) (lane 7), or diap27a/
diap27c (adult) (lane 8). Antitubulin immunoblot analysis was used to
determine equal protein loading. (C) DIAP1 protein levels remain
unchanged in diap2 mutant flies. The level of DIAP1 protein was
examined by immunoblot analysis using anti-DIAP1 and antitubulin
antibodies. Quantification of signals was performed using the LICOR
system. Protein extracts from the following genotypes were analyzed:
CantonS (WT, lane 1), diap27c (lane 2), diap27a (lane 3), or diap27a/
diap27c (lane 4).
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above wild-type levels (Fig. 3A, lanes 5 and 6). Intriguingly, the
“leaky,” low level of DIAP2 transgene expression in diap27c;
UAS-diap2/ animals was sufficient to completely rescue the
immunodeficient phenotype observed in diap27c mutant ani-
mals. Even in the absence of GAL4 drivers, diap27c;UAS-
diap2/ transgenic flies were fully resistant to infection by
gram-negative bacteria and survived microbial exposure like
their wild-type counterparts (Fig. 3B). Similarly, diap27c mu-
tant flies with Act5c- or Da-GAL4-driven expression of UAS-
diap2 were fully resistant to gram-negative bacterial infection,
while diap27c flies died within 25 h of septic injury.
Taken together, these data demonstrate that mutations in
diap2 are phenotypically similar to mutations in Tak1 and
Relish and that these genes are essential for the resistance to
infection by gram-negative bacteria but are dispensable to fend
off gram-positive bacterial or fungal infections. Given that
diap2 mutant animals mounted a normal response to infection
by gram-positive bacteria and fungi, these data indicate that
the immunoresponsive fat body is fully functional in diap2
FIG. 2. DIAP2 is required to resist gram-negative bacterial infec-
tion. The survival rates of adult males in response to different types of
septic injuries are presented. Animals were pricked with a needle
previously dipped into Erwinia carotovora subsp. carotovora 15 (Ecc15)
(A), Enterococcus faecalis (E.faec.) (B), or Candida albicans (C.alb.)
(C). The following genotypes were examined for susceptibility to mi-
crobes: wild-type (OregonR), Tak11, RelishE20, spatzlerm7, EP(G2326),
diap27c/def, diap27c, diap27a, and diap27c/diap27a. Note that diap2 mu-
tant flies behaved as Tak1 and Relish mutant flies, which are known to
be highly susceptible to Erwinia carotovora subsp. carotovora 15 infec-
tion (A), but not to Enterococcus faecalis (B) or Candida albicans
(C) infection. Both diap2 alleles, diap27c and diap27a, hemizygous
(diap27c/def) or transheterozygous flies (diap27c/diap27a) showed simi-
lar susceptibility to E. carotovora subsp. carotovora 15 infection, while
animals of the parental EP(G2326) line were fully resistant (A).
FIG. 3. Ubiquitous expression of DIAP2 fully rescues the immune
deficiency phenotype associated with diap27c. (A) Expression level of
diap2 transgene in otherwise diap2 mutant flies. The presence of
DIAP2 protein was examined by immunoblot analysis using anti-
DIAP2 and antitubulin antibodies. Protein extracts from the following
genotypes were used to monitor DIAP2 protein expression: CantonS
(wild type [WT]) (lane 1), diap27c (lane 2), diap27c; Act5C-GAL4/
(lane 3), diap27c; UAS-diap2/ (lane 4), diap27c; UAS-diap2/Act5C-
GAL4 (lane 5), and diap27c; UAS-diap2/Da-GAL4 (lane 6). Quantifi-
cation of signals was performed using the LICOR system. (B) diap2
transgene expression rescued diap27c mutant flies from the lethal ef-
fects of Erwinia carotovora subsp. carotovora 15 (Ecc15)-mediated sep-
tic injury. The following genotypes were examined for susceptibility to
microbes: wild type (OregonR), Tak11, diap27c, diap27c; Act5C-
GAL4/, diap27c; UAS-diap2/, diap27c; Act5c-GAL4/UAS-diap2, and
diap27c; Da-GAL4/UAS-diap2.
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mutants and that loss of diap2 does not generally affect fat
body development or survival.
DIAP2 is essential for Imd-mediated expression of antibac-
terial peptide genes. Infection by gram-negative bacteria trig-
gers the Imd signal transduction pathway, which culminates in
the transcriptional expression of immune genes, including
those encoding antibacterial peptides (8). The expression of
one such gene, Diptericin, has been established as a reliable
and accurate readout to monitor Imd signaling in response to
infection by gram-negative bacteria (24). On the other hand,
gram-positive bacterial and fungal infections trigger Toll acti-
vation and induced expression of Drosomycin (25, 40). To test
the activation of these pathways in adult diap2 mutant flies, we
monitored Diptericin and Drosomycin expression by quantita-
FIG. 4. diap2 mutant individuals fail to induce antibacterial peptide genes following Erwinia carotovora subsp. carotovora 15 infection. (A and
C) Quantitative RT-PCR analysis of Diptericin (Dipt) induction after E. carotovora subsp. carotovora 15 septic injury (Ecc15 SI) in diap27c,
diap27c/def, Tak11, and RelishE20 mutants, diap27c; UAS-diap2/ and diap27c; UAS-diap2/Da-GAL4 flies, and wild-type (OregonR) adult males.
Results are shown for control (unchallenged) (C) flies and flies 6 and 24 hours after infection. (B) Drosomycin (Drs) induction after Micrococcus
luteus septic injury (M.lut. SI) of wild-type (OregonR), diap27c/def, Tak11, and spatzlerm7 adult males. Results are shown for control (unchallenged)
(C) flies and flies 24 and 48 hours after infection. (D) Attacin-A (AttA), Cecropin-A1 (CecA1), Defensin (Def), Drosocin (Dro), and Metchnikowin
(Mtk) induction 24 h after E. carotovora subsp. carotovora 15 septic injury of wild-type (OregonR), diap27c/def, Tak11, and RelishE20 adult males.
Similar to Tak1 and Relish mutants, diap2 mutant flies were significantly impaired in their ability to induce antibacterial peptide genes in response
to gram-negative bacterial septic injury. However, these mutants showed normal Drosomycin induction following exposure to gram-positive
bacteria. Diptericin induction after E. carotovora subsp. carotovora 15 infection was restored in diap27c mutant flies expressing the UAS-diap2
transgene. rp49 was used as the experimental expression standard. Shown are the relative expression ratios of Dipt/rp49 (A and C), Drs/rp49 (B),
AttA/rp49, CecA1/rp49, Def/rp49, Dro/rp49, and Mtk/rp49 (D).
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tive RT-PCR in response to septic injury with gram-negative
(E. carotovora subsp. carotovora 15 [Fig. 4A]) or gram-positive
bacteria (Micrococcus luteus [Fig. 4B]). Consistent with the
enhanced susceptibility to gram-negative bacteria, we found
that diap2 mutant adult animals displayed a severely compro-
mised immune response to gram-negative bacterial infection.
Like Tak11 and RelishE20 mutant flies, diap2 mutant adult flies
failed to induce expression of the Diptericin gene following E.
carotovora subsp. carotovora 15 septic injury. A compromised
Imd-mediated immune response was already apparent at the
larval stage, since diap2 mutant larvae, like Tak11 and RelishE20
mutants, completely failed to induce Diptericin expression
upon septic injury (data not shown). In contrast, diap2 mu-
tant flies were normal in their ability to signal through the
Toll pathway. M. luteus-mediated induction of Drosomycin
remained unaffected by the diap2 mutation. Likewise,
Drosomycin expression was normal in Tak1 mutant flies fol-
lowing M. luteus septic injury (Fig. 4B). Induced expression
of Drosomycin in response to gram-positive bacterial infection
was abrogated only in spatzle mutant flies. Constitutive trans-
gene-mediated expression of diap2 fully rescued the diap27c
mutant immune deficiency phenotype. diap27c;UAS-diap2/
flies, like diap27c;Da-GAL4/UAS-diap2 or diap27c;Act5c-
GAL4/UAS-diap2 flies, showed close to wild-type induction
of Diptericin expression upon E. carotovora subsp. carotovora
15 infection, while diap27c flies failed to significantly induce
Diptericin expression (Fig. 4C and data not shown).
To study the requirement of diap2 for the expression of
other antibacterial peptide genes, we assessed the expression
of Attacin-A, Cecropin-A1, Defensin, Drosocin, and Metchni-
kowin, all of which have been previously reported to be in-
duced in an Imd-dependent manner following gram-negative
bacterial infection (26). Following E. carotovora subsp. caroto-
vora 15 septic injury, expression of Attacin-A, Cecropin-A1,
Defensin, Drosocin, and Metchnikowin were severely impaired
in diap27c/Def, Tak11, and RelishE20 mutant flies (Fig. 4D).
These results, therefore, indicate that DIAP2 is generally re-
quired for activation of Imd-mediated immune responses,
while it is dispensable for Toll signaling.
Next, we used an oral infection model to study the effects of
the diap2 mutation. In this model, larvae are naturally infected
via the digestive tract through exposure to food contaminated
with E. carotovora subsp. carotovora 15 (Fig. 5) (1). Similar to
the results obtained by septic injury, diap2 mutant larvae that
were exposed to E. carotovora subsp. carotovora 15-contami-
nated food failed to induce expression of Diptericin (Fig. 5A),
Drosocin (Fig. 5B), or Attacin-A (Fig. 5C). diap2 mutant larvae
were similarly immunocompromised as known mutants (Tak11
and RelishE20) of the Imd pathway. Using a natural model of
infection, these data corroborate the notion that DIAP2 is
required for Imd-mediated immune response in vivo.
Epistatic positioning of DIAP2. UAS/GAL4-mediated ex-
pression of imd, Dredd, Tak1, and Relish results in the activa-
tion of the Imd signal transduction pathway causing constitu-
tive Diptericin expression, even in the absence of infecting
microbes (11, 18, 51). We used this system to establish the
epistatic position of DIAP2 in the Imd pathway. Heat shock-
mediated overexpression of imd, Dredd, Tak1, and Relish re-
sulted in induction of Diptericin expression (Fig. 6A). The
ability to induce Diptericin expression varied substantially
among imd, Dredd, Tak1, and Relish, which is consistent with
previous reports (9, 11, 18, 29, 51). Overexpression of imd and
Tak1 was most efficient in inducing Diptericin, with Imd induc-
ing 63.7% and Tak1 53.4% of Diptericin levels observed after
septic injury of control animals. In contrast, overexpression of
Dredd and Relish merely achieved 5.9% and 15.7% of normal
Diptericin expression levels after infection (Fig. 6A). To visu-
alize the contribution of DIAP2 in this system, we set these
Diptericin expression levels as 100% for all subsequent panels.
Intriguingly, in the absence of DIAP2, imd-, Dredd-, Tak1-, and
Relish-mediated induction of Diptericin was blocked (Fig. 6B to
FIG. 5. DIAP2 is required to mount a systemic antibacterial im-
mune response to oral infection by Erwinia carotovora subsp. caroto-
vora (Ecc15). Quantitative RT-PCR analysis of Diptericin (Dipt) (A),
Drosocin (Dro) (B), and Attacin-A (AttA) (C) induction after E. caro-
tovora subsp. carotovora 15 natural infection (Ecc15 NI) in wild-type
(OregonR), diap27c/def, Tak11, and RelishE20 mutant third-instar larvae.
Larvae were orally infected by exposing animals to food contaminated
with E. carotovora subsp. carotovora 15. Similar to Tak1 and Relish
mutants, diap2 mutant individuals failed to significantly induce Atta-
cin-A, Diptericin, and Drosocin expression following natural infection.
rp49 was used as an experimental expression standard. The relative
Dipt/rp49 (A), Dro/rp49 (B), and AttA/rp49 (C) expression values for
control (noninfected) (C) flies and flies 24 h after feeding are shown.
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E). This indicates that diap2 is required for Diptericin induction
by ectopic expression of all these components, corroborating
its vital role in Imd signaling. Thus, in this system, diap2 ap-
pears to function downstream of or parallel to imd, Dredd,
Tak1, and Relish.
Traf2 is not required for an effective immune response trig-
gered by gram-negative bacterial infection. In mammals,
TRAF2 plays a key role in TNFR1-mediated NF-B activation
(3). Following its recruitment to TNFR1, TRAF2 promotes
conjugation of Lys63-linked polyubiquitin chains, which allows
the recruitment and activation of Tak1 and IKK (3). Recently,
it was suggested that the Drosophila Traf2 orthologue contrib-
utes to NF-B-dependent signaling pathways in Drosophila (2).
To test whether Traf2 is required for Imd-mediated immune
responses, we challenged Traf2 null mutant flies with gram-
negative bacteria. Surprisingly, Traf2 mutant flies were fully
resistant to E. carotovora subsp. carotovora 15 septic injury
(Fig. 7). Under the same conditions, diap2 or Tak1 mutant
animals rapidly succumbed to the same microbial load. Thus,
our results demonstrate that Drosophila Traf2 is dispensable to
mount an efficient immune response to infection by gram-
negative bacteria.
FIG. 6. DIAP2 functions genetically downstream of or in parallel
to imd, Dredd, Tak1, and Relish. Quantitative RT-PCR analysis of
Diptericin expression following overexpression of imd, Dredd, Tak1,
and Relish was performed. (A) Diptericin (Dipt) expression levels of
the following animals are shown: control OregonR animals that were
not challenged (OrR - C) and 6 h after Erwinia carotovora subsp.
carotovora 15 septic injury (OrR - 6hr); diap27c/ and diap27c mutant
flies 3 h after 1 h of heat shock at 37°C (diap27c/-HS1 and diap27c-
HS1) or heat shock-mediated overexpression of imd (UAS-imd HS1),
Dredd (UAS-Dredd HS2), Tak1 (UAS-Tak1 HS3), and Relish (UAS-
Relish HS3). (B) In the absence of infection, heat shock-mediated imd
overexpression caused high levels of Diptericin (Dipt) expression
(63.7% of the level of Diptericin observed 6 h after E. carotovora subsp.
carotovora 15 septic injury in panel A) that was significantly thwarted
in diap27c mutant flies (87.8% reduction). (C) Heat shock-mediated
Dredd overexpression triggered weak but reproducible Diptericin ex-
pression (5.9% of the levels of Diptericin observed after 6 h of E.
carotovora subsp. carotovora 15 septic injury in panel A), which was
blocked in diap27c mutant flies. (D) Heat shock-mediated Tak1 over-
expression triggered strong Diptericin expression (53.4% of Diptericin
levels observed after 6 h of E. carotovora subsp. carotovora 15 septic
injury in panel A) which was blocked in diap27c mutants. (E) Heat
shock-mediated Relish overexpression triggered weak but reproducible
Diptericin expression (15.7% of the levels of Diptericin observed after
6 h of E. carotovora subsp. carotovora 15 septic injury in panel A) which
was not observed in diap27c mutant flies. Flies were heat shocked for
1 hour at 37°C and left to recover at 25°C for 3 h (A and B) (HS1), 1 h
(A and C) (HS2), or 24 h (A, D, and E) (HS3) prior to analysis. The
analyzed genotypes were as follows: (i) diap27c/Cyo, act-GFP (diap27c/
), diap27c; (ii) diap27c/Cyo; UAS-imd, hsp-GAL4/TM6Tb (UAS-
imd), diap27c; UAS-imd, hsp-GAL4/TM6Tb; (iii) diap27c/Cyo; UAS-
Dredd/hsp-GAL4 (UAS-Dredd), diap27c; UAS-Dredd/hsp-GAL4; (iv)
diap27c, UAS-Tak1/; hsp-GAL4/ (UAS-Tak1), diap27c, UAS-Tak1/
diap27c; hsp-GAL4/; (v) diap27c, UAS-Relish/; hsp-GAL4/ (UAS-
Relish); (vi) diap27c, UAS-Relish/diap27c; hsp-GAL4/.
FIG. 7. Traf2 is dispensable in resisting gram-negative bacterial
infection. Shown are the survival rates of Traf2 null mutant adult males
exposed to septic injury with E. carotovora subsp. carotovora 15
(Ecc15). The following genotypes were examined: wild type (Ore-
gonR), Tak11, diap27c, and Traf2ex1. Note that Traf2-deficient flies
behaved like wild-type flies, while diap2 and Tak1 mutant flies were
highly susceptible to E. carotovora subsp. carotovora 15-mediated
septic injury.
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DISCUSSION
The Drosophila innate immune response relies mainly on the
differential expression of a variety of small peptides with anti-
microbial activities (19). Depending on the infiltrating mi-
crobe, Drosophila selectively activates two distinct signaling
pathways. While infections by fungi or gram-positive bacteria
stimulate the Toll pathway, infection by gram-negative bacteria
triggers the activation of the immune deficiency (Imd) signaling
cascade. Activation of both Toll- and Imd signaling results in
the activation of NF-B-like transcription factors leading to
the expression of specific sets of antimicrobial peptides (38).
Here, we demonstrate through mutation analysis that DIAP2
plays a pivotal role in the Drosophila innate immune response.
We find that, in vivo, the Drosophila inhibitor of apoptosis
protein DIAP2 is indispensable for Imd-mediated expression
of antibacterial peptide genes. Like known mutants of the Imd
pathway, flies with a mutation in the diap2 gene failed to induce
expression of Attacin-A, Cecropin-A1, Defensin, Diptericin, Droso-
cin, and Metchnikowin and mount an efficient immune reaction
in response to infection by gram-negative bacteria. Conse-
quently, diap2 mutant flies succumbed to gram-negative bac-
terial infection. In contrast, such flies mounted a normal Toll-
dependent immune response and were resistant to infection by
fungi and gram-positive bacteria. Our diap2 null mutant phe-
notype, therefore, demonstrates that DIAP2 is an essential
component of the Imd pathway. Thus, our data are consistent
with recent RNAi studies that have implicated diap2 in the Imd
pathway (12, 23).
DIAP2 is a member of the evolutionarily conserved IAP
family (17). IAPs are classified by the presence of the BIR
domain through which they interact with various “client” pro-
teins (50). Genetic analysis of the Drosophila IAP DIAP1 has
provided some of the most compelling insights into the in vivo
function of this protein family. DIAP1, the first and most
extensively studied Drosophila IAP, is essential for cell survival
and acts as a potent caspase inhibitor (16, 17, 32, 54). Muta-
tions that abrogate physical association of DIAP1 with
caspases cause widespread and unrestrained caspase activa-
tion, leading to cell and organismal death (14, 30, 54, 55). In
contrast to diap1, diap2 null mutants do not show an apparent
cell death phenotype and develop normally. This is unex-
pected, because both these IAPs interact with caspases and
IAP antagonists with similar affinities (27, 52, 53). Moreover,
when overexpressed, DIAP2 can rescue diap1 RNAi-mediated
apoptosis, suggesting that DIAP2 can functionally substitute
for DIAP1 in its ability to regulate caspases (27). Nevertheless,
diap2 mutant animals do not show any apparent apoptosis-
related phenotypes during development. However, these ani-
mals appear to be sensitized to Reaper-mediated killing in the
eye (F. Leulier and P. Meier, unpublished data). The lack of
any apparent gross developmental phenotype may be due to
sufficiently high levels of DIAP1 that may thwart unscheduled
caspase activation in response to loss of DIAP2. In this respect,
it is noteworthy that during embryonic development, the levels
of diap1 mRNA dramatically exceed those of diap2 (17-fold
difference, Berkeley Drosophila Genome Project [BDGP] ex-
pression profiles). Moreover, similarly to c-IAP2 knockout
mice, where a cell death phenotype is revealed only after lipo-
polysaccharide challenge (5), phenotypic manifestation may
become apparent only under certain conditions or in selective
tissues. In agreement with this notion, RNAi-mediated deple-
tion of DIAP2 has no effect on cell viability in unchallenged
tissue culture cells (12, 23) but significantly sensitizes S2 cells
to stress-induced apoptosis (59).
Although IAPs have originally been identified as apoptosis
inhibitors (7), recent evidence suggests that IAPs are multi-
functional signaling devices that, depending on the protein
they interact with, influence diverse biological processes. In
this respect, it is noteworthy that IAPs also carry C-terminal
RING finger domains providing them with E3 ubiquitin-pro-
tein ligase, and hence, signaling activity (50). Thus, in addition
to inhibiting apoptosis, IAPs also fulfill functions that operate
independently of their ability to control caspases and cell death
(50). Therefore, BIR-containing proteins are more precisely
referred to as BIRCs rather than IAPs (43). Consistent with
the notion that BIRCs are multifunctional proteins, the mam-
malian c-IAP1 and c-IAP2 bind to caspases as well as RIP1 and
TRAF2, two components of the TNF receptor signaling com-
plex (34, 37, 41). c-IAP1 or c-IAP2, or both, can promote
ubiquitylation and degradation of TRAF2, RIP1, and NF-B
kinase (IKK)/NF-B essential modulator (NEMO) (34, 50).
Hence, these BIRC proteins are thought to modulate the re-
sponse to TNF. More recently, another BIRC protein was
identified as an important regulator of innate immune surveil-
lance in mammals. BIRC1e (NAIP5) was found to control the
intracellular pathogen Legionella pneumophila, a gram-nega-
tive microbe that causes severe bacterial pneumonia known as
Legionnaires’ disease (56). BIRC1e protects infected host
macrophages by restricting intracellular replication of this
pathogen.
We now find that the Drosophila BIRC protein DIAP2 is
similarly required for innate immune responses and the resis-
tance to gram-negative bacterial infection. diap2 null mutants
become highly susceptible to gram-negative bacteria and fail to
induce antibacterial peptide gene expression. Intriguingly, the
Imd pathway, which is required for antibacterial peptide gene
expression in response to gram-negative microbes, shares sig-
nificant similarities with the TNFR1 signaling cascade. The
notion that the BIRC proteins c-IAP1, c-IAP2, and DIAP2 are
core components of the TNFR1 and Imd pathway, respec-
tively, further reinforces the parallels between the mammalian
TNFR1 pathway and the Imd pathway of Drosophila, pointing
to an evolutionary conservation of these pathways in NF-B
activation (21, 22, 48). Moreover, both pathways seem to rely
on ubiquitin-mediated protein modifications. As in human
cells, where activation of TAK1 and IKK requires the E2
ubiquitin-conjugating enzyme complex Ubc13/UEV1A (3),
Drosophila Ubc13(Bendless)/UEV1A are similarly required
for activating Tak1 and the Drosophila IKK complex (57).
Moreover, recent RNAi data from cultured cells suggest that
Drosophila Tab contributes to Imd signaling, although this still
awaits in vivo validation (12, 23, 58). Therefore, similar to the
TNFR1 pathway, ubiquitin-mediated protein modification is
likely to activate the Tak1/Tab complex via Tab’s ability to bind
to Lys63-linked polyubiquitin chains, thereby recruiting Tak1
to activator platforms. In contrast to the E2 ubiquitin-conju-
gating enzyme complex, little is known about the nature of the
E3 ubiquitin-ligase of the Imd pathway. While TRAF2 is cru-
cial for Ubc13/UEV1A-mediated ubiquitylation in the mam-
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malian TNFR1 pathway, it seems that for Imd signaling Traf2,
the TRAF2/6 orthologue in flies, is not a critical component.
Traf2 null mutation did not completely block NF-B activation
in Drosophila (2). Moreover, our data clearly indicate that
Traf2 mutant flies are fully competent to mount an immune
response and resist gram-negative bacterial infection. Hence,
Traf2 appears not to be essential for an effective Imd-mediated
immune response. Since the Drosophila genome encodes at
least three TRAF family members, it is possible that the loss of
Traf2 function is complemented by other TRAF family mem-
bers. Alternatively, other signaling pathways that bypass Traf2
to transmit the infection signal to NF-B may exit in Drosoph-
ila. In agreement with this notion, RNAi-mediated knockdown
of all three Drosophila TRAFs also did not abrogate Imd-
signaling in S2 cells (23, 47, 57). Thus, an E3 ubiquitin ligase
different from or in addition to Traf2 may be responsible for
Imd signaling in Drosophila. Since DIAP2 carries a RING
finger domain, it represents a likely candidate.
Our genetic epistatic analysis places diap2 downstream of or
parallel to imd, Dredd, Tak1, and Relish. Overexpression of
imd, Dredd, Tak1, and Relish failed to induce Diptericin expres-
sion in diap2 mutant animals, while in wild-type animals, en-
forced expression of these genes, in the absence of any infec-
tion, resulted in reproducible Diptericin induction. Intriguingly,
Diptericin induction following enforced expression of imd and
Dredd is also blocked in Tak1 mutant animals (9, 29), indicat-
ing that both DIAP2 and Tak1 are required downstream of
Dredd. In contrast, kenny and ird5 seem not to be required for
Diptericin induction when Dredd is overexpressed (51). A re-
cent report indicates that Relish cleavage and nuclear translo-
cation on its own are not sufficient for Diptericin expression
and that, at least in vivo, a further cooperative input from the
JNK signaling pathway is required (9). According to this sce-
nario, the Imd signaling pathway bifurcates at the level of
Tak1, with Tak1 activating the NF-B signaling branch as well
as JNK signaling branch, both of which are required for ex-
pression of antibacterial peptide genes in the fat body. In light
of this model, the observation that diap2 acts genetically down-
stream of imd, Dredd, Tak1, and Relish may indicate that
DIAP2 functions at the level of Tak1 (Fig. 8). This view is in
agreement with recent reports from Drosophila tissue culture
cells, which suggest that DIAP2 is required for Tak1-mediated
JNK activation (12, 23). In this respect, DIAP2 functions at the
same epistatic position as the putative E3 ubiquitin ligase of
the Imd pathway. Future biochemical experiments will be re-
quired to test whether DIAP2 is indeed the E3 ubiquitin ligase
that functions together with Ubc13/UEV1A to stimulate Tak1.
Although the underlying mechanism for the impaired induc-
tion of antibacterial peptide gene expression by loss of DIAP2
remains to be defined, the genetic observations made here are
likely to have relevance not only for innate immune responses
in Drosophila but also for TNFR1 signaling in mammals. While
in flies DIAP2 is indispensable for Imd signaling, genetic stud-
ies in mice have, so far, failed to uncover a physiological role
for c-IAP1 and c-IAP2 in TNFR1 signaling (5, 6). Since c-iap1
knockout mice carry significantly elevated levels of c-IAP2
protein, it is feasible that the increased c-IAP2 levels function-
ally compensate for the loss of c-IAP1 (6). Consistently, mam-
malian IAPs have been reported to be under strict homeostatic
control by regulating each other’s protein levels, which pro-
vides a mechanistic explanation for the cross talk among IAPs
(42). Thus, in mammals, double-knockout mice lacking both
c-iap1 and c-iap2 genes will be required to study the roles of
c-IAP1 and c-IAP2 in TNFR1 signaling. Therefore, Drosoph-
ila, where redundancies and compensatory mechanisms are
less problematic, provides an ideal model system to study
caspase-independent functions of IAPs in an in vivo setting.
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